It depends on symptom severity and how you respond
Retatrutide extends the same class further as a triple receptor agonist, targeting the GLP-1, GIP, and glucagon receptors together, with the added glucagon activity aimed at boosting energy expenditure alongside appetite suppression
Benefits Increased energy levels Reduction of fatigue Improved metabolism Improved sleeping patterns Increased concentration Improved mood Boosted immune system Additionally, adequate levels of B12 in the blood are thought to contribute to healthy eyes and may also play an important role in bone health as studies have shown that low levels of B12 can be associated with increased risk of osteoporosis in women You may experience some mild tenderness, redness or swelling around the injection site
Research Combinations Discussed in the Literature AOD-9604 is sometimes discussed alongside Tesamorelin or BPC-157 in research contexts, but the rationale behind pairing these compounds is mechanistic complementarity, not a validated combination protocol no published clinical trial has tested AOD-9604 combined with either compound
Prescription requires licensed clinician approval if deemed medically appropriate